Urgent.News

600+ sources. One page. See who else covered it.

Editions

World

‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker

Mike Doustdar says he is open to ‘large’ deals and group will suffer ‘failures’ as it tries to cut reliance on weight-loss drugs

‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker

We haven't written up this one. Financial Times has the full story — the link below goes straight to it.

Read the original at ft.com →

More in World

More from Tuesday 4 August →